SILO Silo Pharma
- 1.920
- -0.070-3.52%
- 2.010
- +0.090+4.69%
Silo Pharma News
Jaguar Health, Altamira Therapeutics,Erasca Among Healthcare Movers
Silo Pharma Announces Positive Results From Study for Depression Treatment, Remission, and Relapse Prevention
Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine
SARASOTA, FL, May 14, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage biopharmaceutical company focused on developing novel formulations and drug delivery
Silo Pharma | 10-Q: Quarterly report
ING, PALI and FNCH Among Pre-market Losers
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
ATUS, ATHE and GRFS Among Pre-market Losers
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersEliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:
Silo Pharma Exercises Option To License AD Therapeutic SPC-14 From Columbia University
Silo Pharma Set to Acquire Exclusive Licensing for Promising Alzheimer's Disease Therapeutic
SPC-14 shows cognitive and stress reduction benefits in preclinical models SARASOTA, FL, April 10, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO) ("Silo" or the "Company"), a developmental stage
Citizens And 2 Other Stocks Under $3 Insiders Are Buying
The Dow Jones index closed lower by around 10 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders in
Silo Pharma(SILO.US) Officer Buys US$1,988 in Common Stock
$Silo Pharma(SILO.US)$ Officer Weisblum Eric purchased 1,000 shares of common stock on Apr 4, 5, 2024 at an average price of $1.99 for a total value of $1,988.Source: Announcement What is statement of
Silo Pharma CEO Buys Shares Worth $1,988
Silo Pharma Approved Extension Of Previously Announced Stock Repurchase Program Authorizing Purchase Of Up To $1M Common Stock Until April 30
Silo Pharma Approved Extension Of Previously Announced Stock Repurchase Program Authorizing Purchase Of Up To $1M Common Stock Until April 30
Silo Pharma And 3 Other Stocks Under $5 Insiders Are Buying
The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders int
Silo Pharma(SILO.US) Officer Buys US$8,712.52 in Common Stock
$Silo Pharma(SILO.US)$ Officer Weisblum Eric purchased 4,508 shares of Common Stock on Mar 28, Apr 1, 2024 at an average price of $1.93 for a total value of $8,712.52.Source: Announcement What is stat
Psychedelics Headlines: A Form Of Life, Treating Chronic Pain, Microdosing And More
Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the last two weeks of March 2024.See previous edition Psychedelics Headlines: Substitution Survey, Fr
Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence
Intranasal 5-MeO-DMT Clinical Trial Offers Hope For Treatment-Resistant DepressionPartners Beckley Psytech and atai Life Sciences (NASDAQ:ATAI) have jointly announced positive initial results from a P
Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More
FDA Grants Cybin Breakthrough Therapy Status For Major Depression Psilocybin Therapy, Company Announces Positive Clinical Data & Canadian $150M Private PlacementClinical-stage psychedelics biopharma c
Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic
Exclusive license for development, manufacturing, and commercialization in process Silo Pharma to file Pre-IND in first half 2024 SARASOTA, FL, March 20, 2024 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (NASDAQ:SILO)
Analysis
Price Target
No Data
